Effectiveness of Anger Management Treatment in Reducing Anger-Related Behaviors in Female Juvenile Offenders

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
naomi goldstein, Drexel University
ClinicalTrials.gov Identifier:
NCT00720486
First received: July 18, 2008
Last updated: March 26, 2014
Last verified: March 2014
  Purpose

This study will evaluate the effectiveness of an anger management treatment program, Juvenile Justice Anger Management for Girls, in reducing anger-related behaviors displayed by girls in the juvenile justice system.


Condition Intervention
Anger
Behavioral: Juvenile Justice Anger Management (JJAM) for Girls
Behavioral: Treatment as usual

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: Anger Management Treatment for Female Juvenile Offenders

Further study details as provided by Drexel University:

Primary Outcome Measures:
  • Reduction in anger [ Time Frame: Measured at pretreatment, post-treatment, and Month 6 follow-up ] [ Designated as safety issue: No ]

Enrollment: 75
Study Start Date: June 2008
Study Completion Date: February 2012
Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Participants will receive Juvenile Justice Anger Management for Girls plus treatment as usual.
Behavioral: Juvenile Justice Anger Management (JJAM) for Girls
JJAM will include two 1.5-hour group treatment sessions per week for 8 weeks. JJAM sessions will be manual based and will be designed to help youth develop skills in the following areas: identifying different types of physical and relational aggression, recognizing early warning signs of anger, avoiding anger-provoking situations, managing anger to prevent aggression, solving problems, communicating about anger-related events, and repairing relationships damaged by anger-related behaviors.
Behavioral: Treatment as usual
Treatment as usual will include standard activities in the female juvenile justice program.
Active Comparator: 2
Participants will receive treatment as usual.
Behavioral: Treatment as usual
Treatment as usual will include standard activities in the female juvenile justice program.

Detailed Description:

Girls represent a growing segment of the juvenile justice population in the United States, with a large number of them being victims of sexual, physical, and psychological abuse. These girls have special needs in terms of treatment and rehabilitation; however, little research exists on effective mental health treatments for female juvenile offenders in justice facilities. Despite the severity of anger-related behaviors displayed by girls in the juvenile justice system, no anger management treatments have been systematically developed to meet the unique treatment needs of delinquent girls. Treatment programs that provide gender-specific education, counseling, and emotional support are necessary for addressing the aggressive behaviors and psychological distress often displayed among this population. One such treatment program, the Juvenile Justice Anger Management (JJAM) for Girls, is an anger management program adapted from Lochman's Coping Power program, an empirically supported school-based anger management treatment for younger children. This study will evaluate the effectiveness of JJAM for Girls in reducing anger-related behaviors displayed by girls in the juvenile justice system.

Participation in this study will last about 8 months. All participants will first undergo initial assessments that will include a combination of structured interviews, self-report measures, rating scales, and reviews of program behavioral records and incident reports. Participants will then be assigned randomly to receive JJAM for Girls plus treatment as usual or treatment as usual alone. Participants receiving JJAM for Girls will attend two 1.5-hour sessions per week for 8 weeks. Sessions will aim to help youth develop skills in the following areas: identifying different types of physical and relational aggression, recognizing early warning signs of anger, avoiding anger-provoking situations, managing anger to prevent aggression, solving problems, communicating about anger-related events, and repairing relationships damaged by anger-related behaviors. Participants will also complete between-session practice activities that will include practicing skills involved in planning personal goals. Treatment as usual for all participants will include all standard activities in the female juvenile justice program. All participants will repeat the initial assessments at treatment completion and Month 6 of follow-up.

  Eligibility

Ages Eligible for Study:   12 Years to 19 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Assigned to one of the designated juvenile justice facilities
  • Has the ability to speak, read, and understand English sufficiently well to complete the procedures of the study
  • Disposition to the juvenile justice program must last the 8 weeks of scheduled treatment plus 1 week before and after treatment

Exclusion Criteria:

  • Fails to complete pretreatment assessments
  • Current psychotic symptoms, mental retardation, or severe developmental disabilities
  • Considered to be a ward of the state (defined as a youth without a parent, either biological or adoptive, as the legal custodian)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00720486

Locations
United States, Pennsylvania
Drexel University
Philadelphia, Pennsylvania, United States, 19102
Sponsors and Collaborators
naomi goldstein
Investigators
Principal Investigator: Naomi Goldstein, PhD Drexel University
  More Information

No publications provided

Responsible Party: naomi goldstein, PI, Drexel University
ClinicalTrials.gov Identifier: NCT00720486     History of Changes
Other Study ID Numbers: K23 MH070400, K23MH070400, DSIR 82-SEMS
Study First Received: July 18, 2008
Last Updated: March 26, 2014
Health Authority: United States: Federal Government

ClinicalTrials.gov processed this record on August 28, 2014